Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
CEBPA mutation
i
Other names:
CEBPA, CCAAT Enhancer Binding Protein Alpha, CCAAT/Enhancer Binding Protein (C/EBP), Alpha, CCAAT/Enhancer-Binding Protein Alpha, CEBP, CCAAT/Enhancer Binding Protein Alpha, C/EBP-Alpha, C/EBP Alpha
Associations
(7)
News
Trials
C2 | Sensitive
C3 | Sensitive
C4 | Sensitive
D | Sensitive
C2 | Resistant
C3 | Resistant
C4 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
BCL Inhibitors
Chemotherapy
DNA
Other
Tyrosine Kinase Inhibitors
Cancel
Acute Myelogenous Leukemia
venetoclax
C2
CEBPA mutation
|
Acute Myelogenous Leukemia
|
venetoclax
cytarabine/daunorubicin liposomal formulation
C3
CEBPA mutation
|
Acute Myelogenous Leukemia
|
cytarabine/daunorubicin liposomal formulation
quizartinib
C3
CEBPA mutation
|
Acute Myelogenous Leukemia
|
quizartinib
DCAG
C3
CEBPA mutation
|
Acute Myelogenous Leukemia
|
DCAG
paclitaxel + cytarabine + idarubicin hydrochloride
C4
CEBPA mutation
|
Acute Myelogenous Leukemia
|
paclitaxel + cytarabine + idarubicin hydrochloride
venetoclax + IACS-010759
D
CEBPA mutation
|
Acute Myelogenous Leukemia
|
venetoclax + IACS-010759
OICR-9429
D
CEBPA mutation
|
Acute Myelogenous Leukemia
|
OICR-9429
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login